Skip to main content

FDA Approves Pfizer’s Vaccine for Kids 5–11

By: ETFdb
This week, vaccine advisors for the FDA voted affirmatively for an emergency approval for the use of Pfizer’s COVID-19 vaccine in children ages 5–11, a vote of 17-0 with one abstaining, reported CNN.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.